Unknown

Dataset Information

0

Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder.


ABSTRACT: Data from a multiphase schizoaffective disorder study (NCT01193153) were used to examine the effects of paliperidone palmitate once-monthly (PP1M) by subjects' illness duration, defined as recent onset (?5 years since first psychiatric diagnosis; n = 206) and chronic illness (>5 years; n = 461). Symptom and functioning scores, as measured during open-label PP1M acute and stabilization treatment phases, improved in both subpopulations, with greater improvements in recent onset than chronic illness subjects (p ? 0.022). Relapse rates, examined during the double-blind, placebo-controlled phase, were higher with placebo than PP1M: 30.0% vs. 10.2% (p = 0.014; hazard ratio [HR]: 2.8; 95% confidence interval [CI]: 1.11-7.12; p = 0.029) in the recent onset subpopulation and 35.5% vs. 18.1% (p = 0.001; HR: 2.38; 95% CI: 1.37-4.12; p = 0.002) in the chronic illness subpopulation. Growing evidence in the treatment of schizophrenia and schizoaffective disorder supports early intervention with long-acting antipsychotics.

SUBMITTER: Bossie CA 

PROVIDER: S-EPMC5380018 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder.

Bossie Cynthia A CA   Turkoz Ibrahim I   Alphs Larry L   Mahalchick Lucy L   Fu Dong-Jing DJ  

The Journal of nervous and mental disease 20170401 4


Data from a multiphase schizoaffective disorder study (NCT01193153) were used to examine the effects of paliperidone palmitate once-monthly (PP1M) by subjects' illness duration, defined as recent onset (≤5 years since first psychiatric diagnosis; n = 206) and chronic illness (>5 years; n = 461). Symptom and functioning scores, as measured during open-label PP1M acute and stabilization treatment phases, improved in both subpopulations, with greater improvements in recent onset than chronic illnes  ...[more]

Similar Datasets

| S-EPMC6603286 | biostudies-literature
| S-EPMC4898156 | biostudies-literature
| S-EPMC4685865 | biostudies-literature
| S-EPMC5378005 | biostudies-literature
| S-EPMC6207222 | biostudies-literature
| S-EPMC6585630 | biostudies-literature
| S-EPMC7061019 | biostudies-literature
| S-EPMC3431970 | biostudies-literature
| S-EPMC7028061 | biostudies-literature
| S-EPMC4550921 | biostudies-other